Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Meningococcal vaccine groups A C Y W-135 conjugate - sanofi pasteur

Drug Profile

Meningococcal vaccine groups A C Y W-135 conjugate - sanofi pasteur

Alternative Names: MCV-4; Menactra; Menactra Infant/Toddler; Menactra Toddler; Meningo ACWY; Meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine; Meningococcal polysaccharide diphtheria toxoid conjugate vaccine; SP284

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi pasteur
  • Developer Novartis Vaccines; Sanofi Pasteur
  • Class Conjugate vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Meningococcal infections

Most Recent Events

  • 02 Jul 2018 SK Chemicals divested the vaccine business portfolio to a newly formed subsidiary SK Bioscience
  • 05 Dec 2016 Sanofi completes a phase II trial for Meningococcal infections (Prevention, In infants, In children, In adolescents, In adults) in Vietnam (NCT02640404)
  • 19 Aug 2016 Launched for Meningococcal infections (Prevention) in South Korea (IM) prior to August 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top